基于赋能理论的延续护理对COPD病人生存质量的影响

Effects of continuing nursing based on empowerment theory on quality of life of COPD patients

[目的]探讨基于赋能理论的延续护理对慢性阻塞性肺疾病(COPD)病人生存质量的影响。[方法]2017年10月-2018年3月从某三级甲等医院随机选取72例COPD住院病人,对照组给予出院指导、疾病健康宣教,出院后2周进行1次电话随访,1个月进行1次微信群交流随访。干预组在对照组的基础上,给予基于赋能理论的延续护理管理,让病人主动参与疾病管理进程,分别于干预前、干预后1个月、干预后3个月采用St George's呼吸调查问卷(SGRQ)测评COPD病人生存质量。[结果]干预组病人干预前、干预后1个月、干预后3个月SGRQ总分分别为(39.42±12.85)分、(25.64±10.56)分、(20.44±9.93),对照组干预前、干预后1个月、干预后3个月SGRQ总分分别为(39.72±11.16)分、(28.64±9.89)分、(29.72±12.59)分,两组重复测量方差分析显示,时间效应、交互效应比较差异有统计学意义(P<0.05)。[结论]基于赋能理论的延续护理能够提高COPD病人的生存质量。

Objective:To explore the effects of continuing nursing based on empowerment theory on quality of life of COPD patients.Methods:A total of 72 hospitalized patients with COPD in a tertiary grade A hospital,were randomly selected from October 2017 to March 2018.Patients in control group were given discharge guidance,disease-related health education,telephone follow-up every 2 weeks after discharge,and WeChat group communication follow-up every month.On the basis of the control group,patients in intervention group were given continuing nursing management based on empowerment theory.This model could allow patients to actively participate in disease management process.Qualities of life of COPD patients were assessed with St George's respiratory questionnaire(SGRQ)before intervention,one month and three months after the intervention.Results:The total scores of SGRQ of patients in intervention group before intervention,one month and three months after the intervention were 39.42±12.85,25.64±10.56 and 20.44±9.93 respectively.While,the total scores of SGRQ of patients in control group before intervention,one month and three months after the intervention were 39.72±11.16,28.64±9.89 and 29.72±12.59 respectively.Repetitive measure analysis of variance showed that differences in time effect and interaction effect between two groups were statistically significant(P<0.05).Conclusion:Continuing nursing based on empowerment theory can improve the quality of life of patients with COPD.